To determine the status of LSD1 in human prostate cancer, the expression of LSD1 and Nkx3.1, a sensitive specific marker of differentiated adenocarcinoma originating from the prostate [18], was examined in human prostate biopsy specimens by immunohistochemistry and the staining intensity scored. Here, KDM1A is linked to adenocarcinoma.